Flu structure heads to market

21-03-2013

Savira pharmaceuticals has teamed up with Roche to develop new influenza drugs following groundbreaking structural studies performed at the ESRF.

Top image: Key domain of flu virus polymerase with active site shown in red (Image credit: S Cusack/EMBL).

partners

European Synchrotron Radiation Facility - 71, avenue des Martyrs, CS 40220, 38043 Grenoble Cedex 9, France.